Researchers developed a novel penicillin variant that remains inactive until triggered by green light, enabling precise spatial and temporal control over antibiotic activity. This photopharmacological approach targets bacterial infections while reducing systemic exposure and environmental antibiotic resistance emergence. The technology improves on previous UV-based systems, offering safer and clinically relevant activation and promising a paradigm shift in combating antimicrobial-resistant pathogens.